CRRTF News and Press, Coronet Carpets Inc

2024-07-19 07:45:40 ET More on Crescita Therapeutics Crescita to acquire strategic assets of Occy Laboratory Financial information for Crescita Therapeutics Read the full article on Seeking Alpha For further details see: Leading Canadian healthcare servic...

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities, today announced that it has s...

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has signed an exclusive distribution agreement (the “Agreement&...

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has concluded the asset purchase agreement (the “Purchase Agree...

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has agreed to acquire all of the non-real estate business assets of Oc...

2024-05-08 10:06:54 ET More on Crescita Therapeutics Financial information for Crescita Therapeutics Read the full article on Seeking Alpha For further details see: Crescita Therapeutics GAAP EPS of -C$0.03, revenue of C$4.9M

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the first quarter ended March 31, 2024 (“Q1-20...

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the fourth quarter and fiscal year ended December 31,...

2023-11-08 09:11:38 ET More on Crescita Therapeutics Crescita Therapeutics announces approval of normal course issuer bid Financial information for Crescita Therapeutics For further details see: Crescita Therapeutics GAAP EPS of -C$0.06, revenue of C$3.03M

Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 202...